What I found astounding is how shareholders were gullible enough to fork out some $40M over the years, for nothing more than a licence.I love to be on that gig
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025